Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 04 - 27    tags : Cancer    save search

Sun's Out to Play, But So Is Skin Cancer - Here's What Pharma is Doing About It
Published: 2021-04-27 (Crawled : 17:00) - biospace.com/
MYGN | $18.6 0.6% 0.56% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 4.71% C: 0.99%
ALKS | $24.26 0.79% 0.78% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 2.59% C: 0.45%

skin cancer cancer skin pharma
With Anti-CD47 Cancer Drugs Trending, Arch Takes in $105 Million for its Antibody
Published: 2021-04-27 (Crawled : 15:15) - biospace.com/
IMAB | $1.8 0.55% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 1.33% C: -0.32%

cancer antibody drug anti-cd40
With Anti-CD47 Cancer Drugs Trending, Arch Takes in $105 Million for its Anti...
Published: 2021-04-27 (Crawled : 15:15) - biospace.com/
IMAB | $1.8 0.55% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 1.33% C: -0.32%

cancer drug anti-cd40
Guardant Health Announces Collaboration With Daiichi Sankyo to Develop Guardant360® CDx as a Companion Diagnostic for Enhertu® in Advanced Metastatic Non-Small Cell Lung Cancer
Published: 2021-04-27 (Crawled : 14:00) - biospace.com/
GH | News 4 | $17.34 -1.42% -1.44% 1.8M twitter stocktwits trandingview |
Health Services
| | O: 0.13% H: 2.12% C: -0.81%

lung cancer collaboration cancer announces collaboration diagnostic
Compugen Publishes Preclinical Data Demonstrating Therapeutic Potential of COM902 in Cancer Immunology, Immunotherapy
Published: 2021-04-27 (Crawled : 13:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 1.68% C: -0.45%

immunotherapy potential therapy cancer immunology preclinical pre-clinical
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
Published: 2021-04-27 (Crawled : 12:00) - biospace.com/
ARAV | $0.0401 4.74% 4M twitter stocktwits trandingview |
Health Technology
| | O: 9.37% H: 7.38% C: 1.61%

cancer phase 3 ovarian cancer trial
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M twitter stocktwits trandingview |

AGBA | $2.97 137.6% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.59 75.27% 41.8% 2M twitter stocktwits trandingview |

ZAPP | $4.44 50.2% 33.12% 370K twitter stocktwits trandingview |
n/a

MTC | $2.24 43.59% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.045 35.33% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.33 30.39% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.5 25.0% 21.88% 280K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.